What is the recommended dosage of Metoprolol (beta-blocker) for hypertension, angina, or heart failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Metoprolol for Hypertension, Angina, and Heart Failure

For hypertension, angina, and heart failure, metoprolol should be initiated at a low dose and gradually titrated to target doses: metoprolol succinate 12.5-25 mg once daily initially, titrated to 200 mg once daily for heart failure and hypertension; or metoprolol tartrate 25-50 mg twice daily for angina and hypertension.

Metoprolol Formulations and Indications

Metoprolol is available in two primary formulations, each with specific dosing recommendations:

  1. Metoprolol Succinate (Extended-Release):

    • Preferred for heart failure and hypertension
    • Once-daily dosing
    • Maintains more consistent blood levels
  2. Metoprolol Tartrate (Immediate-Release):

    • Used for hypertension and angina
    • Typically twice-daily dosing
    • Also used in acute myocardial infarction settings

Dosing Recommendations by Condition

Heart Failure

  • Initial dose: 12.5-25 mg metoprolol succinate once daily 1
  • Target dose: 200 mg once daily 1, 2
  • Titration: Double the dose every 2 weeks if tolerated 1
  • Only use evidence-based beta-blockers (metoprolol succinate, carvedilol, or bisoprolol) as they have demonstrated mortality reduction 2

Hypertension

  • Metoprolol Succinate:

    • Initial dose: 25-50 mg once daily 3
    • Effective range: 100-400 mg once daily 3
    • Titration: Adjust at 1-2 week intervals based on blood pressure response
  • Metoprolol Tartrate:

    • Initial dose: 50 mg twice daily 3
    • Effective range: 100-450 mg daily in divided doses 3
    • Titration: Adjust at 1-week intervals based on blood pressure response

Angina Pectoris

  • Metoprolol Tartrate:
    • Initial dose: 50 mg twice daily 3
    • Effective range: 100-400 mg daily in divided doses 3, 4
    • Titration: Adjust based on symptom control and exercise tolerance

Acute Myocardial Infarction

  • Initial IV phase: Three 5 mg bolus injections at 2-minute intervals 3
  • Oral maintenance:
    • If IV doses tolerated: 50 mg every 6 hours for 48 hours, then 100 mg twice daily 3, 2
    • If IV doses poorly tolerated: 25-50 mg every 6 hours based on tolerance 3

Special Populations and Precautions

Contraindications

  • Marked first-degree AV block (PR interval >0.24 sec)
  • Second or third-degree heart block without pacemaker
  • Severe bronchial asthma
  • Cardiogenic shock
  • Severe heart failure (for initiation) 2
  • Symptomatic bradycardia or hypotension 2

Dose Adjustments

  • Elderly patients: Start with lower doses due to potential for decreased hepatic/renal function 3
  • Hepatic impairment: Use lower initial doses with cautious titration 3
  • Renal impairment: No dose adjustment typically required 3

Monitoring and Follow-up

  • Monitor heart rate, blood pressure, and clinical status after each dose titration 1
  • Target resting heart rate: 50-60 beats per minute unless limited by side effects 2
  • Watch for signs of worsening heart failure, especially during initiation phase
  • For patients with borderline bradycardia (HR 50-60 bpm), closer monitoring is essential 1

Clinical Pearls

  • "Start low, go slow" approach is essential, particularly in heart failure patients 1
  • Beta-blockers should be continued indefinitely in heart failure patients with reduced ejection fraction, even if symptoms improve 1
  • The extended-release formulation (succinate) is preferred for heart failure based on mortality benefit evidence 2
  • In one comparative trial, carvedilol showed greater mortality reduction than immediate-release metoprolol tartrate, but there have been no direct comparisons between carvedilol and metoprolol succinate at target doses 2
  • Metoprolol succinate has been shown to reduce all-cause mortality by 34% in patients with heart failure 2, 1, 5

By following these dosing guidelines and monitoring protocols, metoprolol can effectively reduce morbidity and mortality in patients with hypertension, angina, and heart failure.

References

Guideline

Heart Failure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.